Current and future roles of biochemical biomarkers in hypertrophic cardiomyopathy

被引：2
作者：
Dimitrow, Pawel Petkow [1 ]
机构：
[1] Jagiellonian Univ, Coll Med, Dept Cardiol 2, Krakow, Poland
来源：
BIOMARKERS IN MEDICINE | 2014年 / 8卷 / 01期
关键词：
biomarker; hypertrophic cardiomyopathy; sudden death; COLD PRESSOR TEST; MYOCARDIAL FIBROSIS; SYMPTOMATIC PATIENTS; CORONARY VASOMOTION; MAGNETIC-RESONANCE; OXIDATIVE STRESS; DYSFUNCTION; SEVERITY; INFLAMMATION; VERAPAMIL;
D O I：
10.2217/bmm.13.119
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：81 / 83
页数：3
相关论文
共 50 条
  • [31] Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy
    Fang, Lu
    Ellims, Andris H.
    Moore, Xiao-lei
    White, David A.
    Taylor, Andrew J.
    Chin-Dusting, Jaye
    Dart, Anthony M.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [32] Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy
    Lu Fang
    Andris H. Ellims
    Xiao-lei Moore
    David A. White
    Andrew J. Taylor
    Jaye Chin-Dusting
    Anthony M. Dart
    Journal of Translational Medicine, 13
  • [33] Art and science of risk stratification of sudden cardiac death in hypertrophic cardiomyopathy: Current state, unknowns, and future directions
    Siontis, Konstantinos C.
    Ommen, Steve R.
    Geske, Jeffrey B.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2023, 80 : 25 - 31
  • [34] Integrated Imaging in Hypertrophic Cardiomyopathy
    Choudhury, Lubna
    Rigolin, Vera H.
    Bonow, Robert O.
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (02) : 328 - 339
  • [35] Plasma concentration of fibronectin is decreased in patients with hypertrophic cardiomyopathy
    Fucikova, Alena
    Lenco, Juraj
    Tambor, Vojtech
    Rehulkova, Helena
    Pudil, Radek
    Stulik, Jiri
    CLINICA CHIMICA ACTA, 2016, 463 : 62 - 66
  • [36] Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: Potential for refinement of current criteria
    Desai, Milind Y.
    Smedira, Nicholas G.
    Dhillon, Ashwat
    Masri, Ahmad
    Wazni, Oussama
    Kanj, Mohamad
    Sato, Kimi
    Thamilarasan, Maran
    Popovic, Zoran B.
    Lever, Harry M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 156 (02) : 750 - +
  • [37] The weight of obesity in hypertrophic cardiomyopathy
    Zaromytidou, Marina
    Savvatis, Konstantinos
    CLINICAL MEDICINE, 2023, 23 (04) : 357 - 363
  • [38] Left Ventricular Remodeling in Hypertrophic Cardiomyopathy: An Overview of Current Knowledge
    Musumeci, Beatrice
    Tini, Giacomo
    Russo, Domitilla
    Sclafani, Matteo
    Cava, Francesco
    Tropea, Alessandro
    Adduci, Carmen
    Palano, Francesca
    Francia, Pietro
    Autore, Camillo
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [39] Blood-based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta-analysis
    Jansen, Mark
    Algul, Sila
    Bosman, Laurens P.
    Michels, Michelle
    van der Velden, Jolanda
    de Boer, Rudolf A.
    van Tintelen, J. Peter
    Asselbergs, Folkert W.
    Baas, Annette F.
    ESC HEART FAILURE, 2022, 9 (05): : 3418 - 3434
  • [40] Current perspectives of sudden cardiac death management in hypertrophic cardiomyopathy
    Pu, Lutong
    Li, Jialin
    Qi, Weitang
    Zhang, Jinquan
    Chen, Hongyu
    Tang, Zihuan
    Han, Yuchi
    Wang, Jie
    Chen, Yucheng
    HEART FAILURE REVIEWS, 2024, 29 (02) : 395 - 404
12345